PRD Therapeutics, Inc. is a biopharmaceutical company focused on the development of First-in-Class oral drugs targeting lipid metabolism diseases. Their lead drug, PRD001, is designed for the treatment of rare diseases such as Homozygous-familial hypercholesterolemia (HoFH), Lysosomal Acid Lipase Deficiency (LAL-D), and NASH/NAFLD. As a company founded in 2021, PRD Therapeutics operates within the Biopharma, Biotechnology, and Pharmaceutical sectors, with a strong focus on addressing unmet medical needs in rare disease populations. With their innovative drug development approach, they aim to make a significant impact on patients' lives and the healthcare industry as a whole.
PRD Therapeutics, Inc.
Development of First-in-Class oral drugs for lipid metabolism diseases
Founded 2021
Japan
3 employees
Biopharma, Biotechnology +1
Japan
3 employees
Biopharma, Biotechnology +1
General Information
Get notified when PRD Therapeutics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track PRD Therapeutics, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Japan Market
Biopharma
About PRD Therapeutics, Inc.
Taxonomy: pharmaceuticals, drug development, lipid metabolism, rare diseases, oral drugs, therapeutics, NASH, NAFLD, medical research
No funding data available for PRD Therapeutics, Inc. yet.
Get notified when PRD Therapeutics, Inc. raises fundingPRD Therapeutics, Inc. Alternatives & Competitors
PRD Therapeutics, Inc. vs
PRD Therapeutics, Inc. vs
PRD Therapeutics, Inc. vs
Rare Diagnostics accelerates rare disease diagnosis through daily reporting and algorithm-powered Ra...
Grant
Health Care, Health and Wellness
FAQ About PRD Therapeutics, Inc.
Development of First-in-Class oral drugs for lipid metabolism diseases
PRD Therapeutics, Inc. was founded in 2021.
PRD Therapeutics, Inc. is headquartered in Japan.
PRD Therapeutics, Inc. operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
PRD Therapeutics, Inc. has approximately 3 employees.
Top alternatives and competitors to PRD Therapeutics, Inc. include Alexion Pharmaceuticals, Inc., Patient Worthy, Rare Diagnostics, RareStone Group, Havas Life Rare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PRD Therapeutics, Inc. and Alexion Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors PRD Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.